1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CCR
  4. CCR2 Isoform
  5. CCR2 Inhibitor

CCR2 Inhibitor

CCR2 Inhibitors (3):

Cat. No. Product Name Effect Purity
  • HY-101713
    Ilacirnon
    Inhibitor 99.87%
    CCX140 (CCX140-B) is a potent CCR2 antagonist.
  • HY-P99781
    Plozalizumab
    Inhibitor
    Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research.
  • HY-13499
    JNJ-41443532
    Inhibitor 99.65%
    JNJ-41443532 (CCR2 antagonist 5) is a selective, orally active hCCR2 inhibitor with good binding affinity (IC50=37 nM) and potent functional antagonism (chemotaxis IC50=30 nM). JNJ-41443532 displays a Ki of 9.6 µM for mCCR2 binding. JNJ-41443532 can be used in the research of inflammatory disease.